GleamWall
中文EN

SRTS Sensus Healthcare, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1494891 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-53.3%
TTM net income YoY-433.4%
TTM EPS YoY-438.9%
Revenue 3-yr CAGR-12.7%
Net income 3-yr CAGR—

Margins

Gross margin41.8%
Operating margin-74.0%
Net margin-96.5%
FCF margin-69.4%
EBITDA margin-71.9%

Returns

ROE-37.0%
ROA-32.4%
ROIC (approx.)-39.5%
Asset turnover0.34x

Leverage & solvency

Liabilities / assets12.6%
Debt / equity0.00x
Current ratio6.77x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.71x
Accruals ratio-9.5%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$6.00M$2.29M$3.39M$4.94M$6.88M$7.32M$8.34M$13.07M
Cost of revenue$2.71M$1.52M$2.40M$3.04M$4.17M$4.41M$3.99M$5.96M
Gross profit$3.29M$769,000$991,000$1.90M$2.71M$2.90M$4.35M$7.11M
R&D expense$1.11M$1.11M$1.59M$1.88M$1.82M$1.47M$2.61M$1.56M
SG&A expense$2.25M$1.79M$2.04M$1.76M$1.92M$1.99M$2.21M$2.42M
Operating income-$1.62M-$3.18M-$4.36M-$3.15M-$2.57M-$1.94M-$2.65M$1.73M
Interest expense—————-$183,000-$184,000—
Pretax income-$1.49M-$3.06M-$4.23M-$2.99M-$2.41M-$1.76M-$2.46M$1.96M
Income tax$0$5.69M-$1.61M$174,000-$1.47M-$723,000$110,000$410,000
Net income-$1.49M-$8.75M-$2.63M-$3.17M-$943,000-$1.04M-$2.57M$1.55M
EBITDA-$1.54M-$3.09M-$4.26M-$3.05M-$2.47M-$1.84M-$2.56M$1.81M
EPS (basic)-0.09-0.53-0.16—-0.06-0.06-0.16—
EPS (diluted)-0.09-0.53-0.16—-0.06-0.06-0.16—
Weighted avg. shares (diluted)16.46M16.46M16.46M—16.32M16.32M16.34M—
Banking
Net interest income$126,000$117,000$125,000$155,000$160,000$183,000$184,000$230,000
Balance sheet
Cash & equivalents$12.92M$15.19M$18.33M$22.08M$24.45M$22.16M$19.07M$22.06M
Receivables$1.40M$1.68M$3.58M$6.04M$9.34M$12.62M$18.02M$19.73M
Inventory$17.96M$18.46M$16.50M$14.56M$13.04M$12.40M$9.92M$10.10M
Current assets$34.58M$37.68M$42.59M$45.89M$50.20M$52.22M$54.20M$56.74M
PP&E, net$2.66M$2.75M$2.31M$1.98M$2.52M$2.71M$2.68M$2.00M
Total assets$40.55M$41.26M$51.55M$53.04M$58.30M$58.85M$60.21M$62.16M
Current liabilities$5.11M$4.33M$5.86M$4.72M$6.80M$6.41M$6.72M$5.88M
Total liabilities$5.11M$4.40M$6.00M$4.94M$7.10M$6.79M$7.18M$6.34M
Shareholders' equity$35.44M$36.86M$45.54M$48.10M$51.19M$52.06M$53.03M$55.83M
Shares outstanding16.46M16.46M16.46M16.46M16.44M16.44M16.45M16.50M
Cash flow statement
Operating cash flow-$2.26M-$3.13M-$3.75M-$2.21M$2.29M$3.12M-$2.68M-$827,000
Capital expenditure$5,000$8,000$3,000$158,000$4,000$27,000$7,000-$297,000
Free cash flow-$2.27M-$3.14M-$3.76M-$2.37M$2.29M$3.09M-$2.68M-$530,000
Investing cash flow-$5,000-$8,000-$3,000-$158,000-$4,000-$27,000-$7,000$297,000
Financing cash flow———-$5,000$0$0-$300,000$28,000
Depreciation & amortization$81,000$86,000$96,000$100,000$98,000$99,000$86,000$85,000
Stock-based compensation$70,000$70,000$70,000$76,000$0$5,000$79,000$122,000
Share buybacks———$0$0$0$300,000—

Free plan shows the latest 8 periods; Pro shows all 46 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.